In 1987 David Riggins was arrested in Las Vegas and charged with murdering Paul Wade, who had been stabbed 32 times. While confined in the Clark County Jail awaiting trial, Riggins complained to Dr. R. Edward Quass, a psychiatrist who treated jail patients, about hearing voices and having trouble sleeping. Dr. Quass prescribed Mellaril (thioridazine), a potent antipsychotic medication. The dose started at 100mg per day and was raised to 800mg per day before trial began.
Before trial, Riggins moved to have the Mellaril suspended. He offered two arguments. First, he had a liberty interest under the Due Process Clause in refusing unwanted antipsychotic medication, a right the Court had recognized the year before in Washington v. Harper. Second, and more practically, he was mounting an insanity defense. The jury would need to evaluate his mental state, but the medication was actively altering it. The medicated version of him that the jury would see was not the person who allegedly committed the crime. His demeanor, his testimony, his ability to communicate with his lawyers, his affect on the stand: all of it was being chemically managed in ways the jury would not observe and might not understand.
The Nevada trial court denied the motion without any explanation. No findings. No analysis. No consideration of whether the medication was medically necessary, whether it could be reduced or replaced, or whether Riggins's trial rights were implicated. He was convicted of first-degree murder and robbery and sentenced to death. The Nevada Supreme Court affirmed, reasoning that the expert testimony about Mellaril's effects was sufficient for the jury to account for the drug's impact on his behavior.
The Supreme Court took the case to decide whether forcing a criminal defendant to take antipsychotic medication throughout his trial, without any judicial finding of necessity or any consideration of alternatives, satisfied due process.